Qing-Xin-Jie-Yu Granule for patients with stable coronary artery disease (QUEST Trial): A multicenter, double-blinded, randomized trial.

CONCLUSION: In patients with SCAD, the addition of QXJYG to standard therapy was associated with reduced risk of nonfatal MI and the composite 'hard' endpoint of cardiovascular death, nonfatal MI and stroke. (http://www.chictr.org.cn/showproj.aspx?proj=5200, ChiCTR-TRC-13004370).
PMID: 31780034 [PubMed - in process]

Source: Complementary Therapies in Medicine - November 30, 2019 Category: Complementary Medicine Authors: Li J, Gao Z, Zhang L, Li S, Yang Q, Shang Q, Gao X, Qu H, Gao J, Shi L, Liu Y, Du J, Xu H, Shi D Tags: Complement Ther Med Source Type: research